CinCor Pharma, Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CinCor Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2021.
  • CinCor Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$1.27M, a 195% decline year-over-year.
  • CinCor Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was $8.53M.
  • CinCor Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $7.86M, a 570% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $7.86M +$6.69M +570% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-22
2020 $1.17M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.